ECRM_1170x120_8-1-17

health care costs

NACDS backs Preventive Health Savings Act

NACDS backs Preventive Health Savings Act

ARLINGTON, Va. — The National Association of Chain Drug Stores has voiced support of impending legislation that would highlight the value of disease prevention and wellness in lowering health care costs. NACDS said it has joined the Healthcare Leadership Council and other stakeholders in a letter to Congress backing the expected reintroduction of the Preventive

Health care stakeholders need to talk

Health care stakeholders need to talk

With the heated rhetoric about Obamacare on the presidential campaign trail, congressional hearings focused on drug costs and news reports about these debates, is it possible for all health care stakeholders to work together to develop solutions for containing costs that ensure patient access to care and appropriate treatments and encourage future innovation? We believe

Balancing drug cost vs. access a challenge

Balancing drug cost vs. access a challenge

PARSIPPANY, N.J. — Growth in spending on medicines dipped last year, but that hasn’t eased the challenge of balancing access to drugs and the cost of care in an era of innovative but more expensive treatments, according to the IMS Institute for Healthcare Informatics. For the second year, medication spending climbed by double digits in

Big companies eye health costs

Big companies eye health costs

NEW YORK — Twenty of the country’s largest corporations, including American Express Co., Coca-Cola Co. and Macy’s Inc., have banded together to rein in employee health care costs. The companies have formed Health Transformation Alliance (HTA) to break with wasteful and inefficient marketplace practices that have resulted in employees paying higher premiums, co-payments and deductibles

Health care reform process far from over

Health care reform process far from over

The major provisions of the Patient Protection and Affordable Care Act have been in effect for almost two years now, enough time to undertake an interim analysis of the controversial law’s impact on the health care system. President Obama and other advocates of the ACA, which since its enactment in March 2010 has withstood two